Atlas Trials

A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease

Clinical trial NCT04428775 · TERMINATED

Trial details

NCT number
NCT04428775
Sponsor
AZTherapies, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Amyotrophic Lateral Sclerosis
Start date
2020-09-08
Primary completion
2021-10-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.